Wellcome genetically engineered hepatitis B vaccine immune effects 2 China Medical 13 to] 999 years l0 months vaccinated with a small observation, the results reported below were converted to positive. The rest were negative. 1 Materials and methods observed object 1998. I stood out-patient by ELISA seized swaddling clothes I had liver five indicators were negative, age 1 to 65 years of age. Yeast recombinant genetically engineered hepatitis B vaccine, vaccination Shenzhen Kangtai Biological Products Co., Ltd. production, according to the manufacturers recommended dose of 5g three-pin, 0, l, in June. Complete the full immunization, 337. 30 days after the completion of the third dose (T) for serological testing. Vaccines within the validity period. 2 Results and analysis of local and systemic were not aware of any serious reactions after vaccination of 2.1 vaccination reactions, only a few people at the inoculation site less than 2.5cm in diameter induration, a little tenderness, and disappear in the 1 ~ 2d. 2.2 The immune effect of anti-HBs positive rate was 95.85. Vaccinated subjects were divided into ( l8 years of age). The immune effect of all ages a significant difference (= 0.457, P> 0.05). Results are shown in Table 1. Table 1, genetically engineered hepatitis B vaccine effect (,) 2.3 non-responders to enhance the effect of injection strengthening the injection of l-pin with the original of the same type of dose on antibody negative vaccine. After the review of an October l4 out of 3r-f CT analysis of 043 cases of hepatic hemangioma Li Xueping Rain People’s Hospital Department of Radiology, Guigang 537100) Keywords CT scan {hepatic hemangioma hepatic hemangioma is the most common hepatic benign tumor preoperative identification of malignant liver tumors. Now our hospital from 1996 to 1999 confirmed the scorpionfish cases of hepatic hemangioma cases for analysis are as follows. 1 Materials and Methods 1.1 Data of 43 cases, male 20 cases, female 23 down, 23 to 67 years of age, more common 35 to 50 years old, average 47-year-old. These became ill and the diagnosis confirmed by surgery, angiography or ultrasound, II bed, laboratory, marrow visit such as comprehensive. the l_2 method using a Shimadzu CT machine, thickness of 10mm continuous scanning, are 198.3 discuss the results of this survey, genetic engineering had the Hepatitis B vaccine according to the manufacturers recommended dose routine immunization, immune antibody positive rate high selection of more than 95, and non-toxic-cut role in discovery. A vaccine protective efficacy and safe, reliable. Genetically engineered hepatitis B vaccine virus surface antigen expression by the recombinant yeast culture were purified, inactivated and adjuvanted adsorbed made called. Immunogenic, to vibration extensive, and does not contain any blood Qi were less susceptible to lower blood products other viruses, pollution, and Qi car easily people accept. Recombinant vaccine in foreign countries has been large-scale application and gradually replace the small blood vibration vaccines in China will become more and more widely. But at the same time should see. The genetically engineered vaccine through routine immunization, there are still steps people can not produce antibodies. About 5 or so. Referred to as non-responders. Respondents to produce the mechanism is not yet clear, but researchers found that first-degree relatives of nonresponders HVB infection rate was significantly higher than the strong response, the immune response to the vaccine were significantly lower than the strong response. That its occurrence and to the genetic characteristics of the body, there may be a genetic susceptibility]. People suffered HVB attack, the easier formation of I-IBsAG chronic carrier state, ten special high-risk groups. Should be taken seriously enough.